These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 20568067

  • 1. [Intraduodenal infusion of levodopa].
    Valldeoriola F, Cámara A.
    Rev Neurol; 2010 Jul 01; 51(1):41-8. PubMed ID: 20568067
    [Abstract] [Full Text] [Related]

  • 2. Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease.
    Nyholm D.
    Expert Rev Neurother; 2006 Oct 01; 6(10):1403-11. PubMed ID: 17078781
    [Abstract] [Full Text] [Related]

  • 3. [Continuous treatment with levodopa of Parkinson disease].
    Lundqvist C, Nystedt T, Reiertsen O, Grotli R, Beiske AG.
    Tidsskr Nor Laegeforen; 2005 Oct 06; 125(19):2638-40. PubMed ID: 16215609
    [Abstract] [Full Text] [Related]

  • 4. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
    Nyholm D, Nilsson Remahl AI, Dizdar N, Constantinescu R, Holmberg B, Jansson R, Aquilonius SM, Askmark H.
    Neurology; 2005 Jan 25; 64(2):216-23. PubMed ID: 15668416
    [Abstract] [Full Text] [Related]

  • 5. [Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].
    Annic A, Devos D, Seguy D, Dujardin K, Destée A, Defebvre L.
    Rev Neurol (Paris); 2009 Jan 25; 165(8-9):718-27. PubMed ID: 19150100
    [Abstract] [Full Text] [Related]

  • 6. Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome.
    Antonini A, Isaias IU, Canesi M, Zibetti M, Mancini F, Manfredi L, Dal Fante M, Lopiano L, Pezzoli G.
    Mov Disord; 2007 Jun 15; 22(8):1145-9. PubMed ID: 17661426
    [Abstract] [Full Text] [Related]

  • 7. Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.
    Antonini A, Mancini F, Canesi M, Zangaglia R, Isaias IU, Manfredi L, Pacchetti C, Zibetti M, Natuzzi F, Lopiano L, Nappi G, Pezzoli G.
    Neurodegener Dis; 2008 Jun 15; 5(3-4):244-6. PubMed ID: 18322402
    [Abstract] [Full Text] [Related]

  • 8. Transcutaneous port for continuous duodenal levodopa/carbidopa administration in Parkinson's disease.
    Meppelink AM, Nyman R, van Laar T, Drent M, Prins T, Leenders KL.
    Mov Disord; 2011 Feb 01; 26(2):331-4. PubMed ID: 20960486
    [Abstract] [Full Text] [Related]

  • 9. Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel by jejunal extension tube placement through percutaneous endoscopic gastrostomy for patients with advanced Parkinson's disease: a preliminary study.
    Zulli C, Sica M, De Micco R, Del Prete A, Amato MR, Tessitore A, Ferraro F, Esposito P.
    Eur Rev Med Pharmacol Sci; 2016 Jun 01; 20(11):2413-7. PubMed ID: 27338069
    [Abstract] [Full Text] [Related]

  • 10. [Benefit of L-DOPA-without-DCI (decarboxylase inhibitor) therapy on wearing-off phenomenon in advanced stages of Parkinson's disease patients].
    Hironishi M, Miwa H, Kondo T.
    No To Shinkei; 2002 Feb 01; 54(2):127-32. PubMed ID: 11889758
    [Abstract] [Full Text] [Related]

  • 11. Enteral levodopa/carbidopa infusion in advanced Parkinson disease: long-term exposure.
    Nyholm D, Lewander T, Johansson A, Lewitt PA, Lundqvist C, Aquilonius SM.
    Clin Neuropharmacol; 2008 Feb 01; 31(2):63-73. PubMed ID: 18382177
    [Abstract] [Full Text] [Related]

  • 12. [Experience with continuous levodopa enteral infusion (Duodopa(®)) in patients with advanced Parkinson's disease in a secondary level hospital].
    Santos-García D, Macías M, Llaneza M, Fuster-Sanjurjo L, Echarri-Piudo A, Belmonte S, Blanco S.
    Neurologia; 2010 Feb 01; 25(9):536-43. PubMed ID: 21093702
    [Abstract] [Full Text] [Related]

  • 13. Carbidopa levodopa enteral suspension.
    Seeberger LC, Hauser RA.
    Expert Opin Pharmacother; 2015 Feb 01; 16(18):2807-17. PubMed ID: 26595228
    [Abstract] [Full Text] [Related]

  • 14. [Levodopa intestinal infusion therapy in Parkinson's disease].
    Sławek J, Bogucki A.
    Neurol Neurochir Pol; 2010 Feb 01; 44(4):396-403. PubMed ID: 20827613
    [Abstract] [Full Text] [Related]

  • 15. Treatment of Parkinson's disease: levodopa as the first choice.
    Katzenschlager R, Lees AJ.
    J Neurol; 2002 Sep 01; 249 Suppl 2():II19-24. PubMed ID: 12375059
    [Abstract] [Full Text] [Related]

  • 16. Duodenal delivery of levodopa for on-off fluctuations in parkinsonism: preliminary observations.
    Kurlan R, Rubin AJ, Miller C, Rivera-Calimlim L, Clarke A, Shoulson I.
    Ann Neurol; 1986 Aug 01; 20(2):262-5. PubMed ID: 3752968
    [Abstract] [Full Text] [Related]

  • 17. Clinical experiences with levodopa methylester (melevodopa) in patients with Parkinson disease experiencing motor fluctuations: an open-label observational study.
    Zangaglia R, Stocchi F, Sciarretta M, Antonini A, Mancini F, Guidi M, Martignoni E, Pacchetti C.
    Clin Neuropharmacol; 2010 Aug 01; 33(2):61-6. PubMed ID: 19935405
    [Abstract] [Full Text] [Related]

  • 18. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H, Antonini A, Martinez-Martin P, Forgacs I, Faye GC, Fox T, Fox K, Mancini F, Canesi M, Odin P, Chaudhuri KR.
    Mov Disord; 2009 Jul 30; 24(10):1468-74. PubMed ID: 19425079
    [Abstract] [Full Text] [Related]

  • 19. Continuous jejunal levodopa infusion in patients with advanced parkinson disease: practical aspects and outcome of motor and non-motor complications.
    Eggert K, Schrader C, Hahn M, Stamelou M, Rüssmann A, Dengler R, Oertel W, Odin P.
    Clin Neuropharmacol; 2008 Jul 30; 31(3):151-66. PubMed ID: 18520982
    [Abstract] [Full Text] [Related]

  • 20. Duodopa pump treatment in patients with advanced Parkinson's disease.
    Karlsborg M, Korbo L, Regeur L, Glad A.
    Dan Med Bull; 2010 Jun 30; 57(6):A4155. PubMed ID: 20515603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.